Scopus BioPharma Inc.
SCPS · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,929 | -$2,680 | -$1,836 | -$1,899 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | -$3,234,800 | $0 |
| Stock-Based Comp. | $78 | $78 | $78 | $84 |
| Change in WC | $1,841 | $1,841 | $1,336 | $963 |
| Other Non-Cash | $0 | $0 | $3,234,800 | $0 |
| Operating Cash Flow | -$1,009 | -$760 | -$422 | -$852 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$1,550 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$1,550 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$45 | $2,019 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $242 | $0 |
| Financing Cash Flow | -$45 | $2,019 | $242 | $0 |
| Forex Effect | $15 | $17 | -$6 | $6 |
| Net Chg. in Cash | -$1,039 | $1,277 | -$186 | -$846 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,401 | $125 | $311 | $1,156 |
| End Cash | $362 | $1,401 | $125 | $311 |
| Free Cash Flow | -$1,009 | -$760 | -$1,972 | -$852 |